World Health Organization : Report on a European Syposium Convened by the Regional Office for Europe Pts Ida, No. 74.5: International Drug Abstracts ; December 1974

By World Health Organization

Book Id: WPLBN0000212564
Format Type: PDF eBook
File Size: 0.5 MB
Reproduction Date: 2005

Title:	World Health Organization : Report on a European Syposium Convened by the Regional Office for Europe Pts Ida, No. 74.5: International Drug Abstracts ; December 1974
Author:	World Health Organization
Volume:
Language:	English
Subject:	Health., Public health, Wellness programs
Collections:	Medical Library Collection, World Health Collection
Historic Publication Date:
Publisher:	World Health Organization


Citation APA MLA Chicago Organization, W. H. (n.d.). World Health Organization : Report on a European Syposium Convened by the Regional Office for Europe Pts Ida, No. 74.5. Retrieved from https://self.gutenberg.org/

Description
Medical Reference Publication

Excerpt
PHARMACOKINETIC DRUG INTERACTIONS (Abstracted from The Journal of the American Medical Association, Vol. 229, No. 11, pp. 1485-1488, September 9, 1974) This article, authored by Dr M.E. Rosman, presents a comprehensive review of the pharmacokinetic basis of the mechanism of interactions through metabolic pathways, drug distribution and drug absorption. Clinical applications of the pharmacokinetic interaction of the ssdative, hypnotic and anti-anxiety agents are more specifically discussed in their relation to anticoagulant, antidepressant/antipsychotic, anticonvulsant , cardiovascular, corticosteroid and antifungal agents. Requests for reprints should be addressed to: Department of Drugs, American Medical Association, 535 North Dearborn Street, Chicago, Illinois 60610, United States of America.

Table of Contents
Pharmacokinetic drug interactions .......................................... 3 Drug bioequivalence ........................................................ 3 Availability is denied of 101 ethical products -Efficacy Review Panel ..... 4 Treatment of immediate hypersensitivity reactions to drugs ................. 4 National Drugs Advisory Board . annual report 1973 ......................... 4 Folia Pharmacotherapeutica ................................................. 4 Seminar on manufacture and quality control under contract .................. 5 Australian government to launch drug journal ............................... 5 Regulation on expiry dates ................................................. 5 Regulations on insulin .................................................... 6 Danish Board on Adveree Reactions to Drugs ................................. 6 I1 . REPORTS ON INDIVIDUAL DRUGS 1 . oral contracs~tives reviewed ............................................... 6 2 . Radiopharmaceuticals ....................................................... 7 3 . Reevaluation of cyclamate .................................................. 7 4 . Reserpine .................................................................. 7 5 . Cannabis ............................................................. 8 6 . Therapeutic effectiveness of methadone maintenance programs in the USA ..... 9 7 . Colitis associated with clindamycin ........................................ 9 8 . Lithium - its role in psychiatric research and treatment ................... 9 9 . Comments on the incidence and reporting of adverse reactions to contrast media ................................................................... 9 lo . FDA guidelines for psychotroplc drugs (Draft - June 1974) .................. 10 I I1 . MISCELLANEOUS . ................................. 1 9th International Congress of Chemotherapy 10 2 . European Pharmacopoeia ..................................................... 10